New spinal fluid test aims to distinguish lewy body dementia from Alzheimer's
NCT ID NCT07166744
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study will test whether measuring a specific form of the protein alpha-synuclein in spinal fluid can reliably distinguish dementia with Lewy bodies (DLB) from Alzheimer's disease. Currently, misdiagnosis is common and can be dangerous because many DLB patients have severe reactions to certain medications. The study plans to enroll 286 adults aged 50 and older who show signs of either condition, and will compare the new test results against standard diagnostic methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.